Lv11
70 积分 2024-10-28 加入
Defining immune reset: achieving sustained remission in autoimmune diseases
4小时前
待确认
Preclinical evaluation of efficacy and cytokine release of bispecific T cell engagers in humanized NSG mice
11天前
已关闭
Fifty years of monoclonals: the past, present and future of antibody therapeutics
15天前
已完结
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME
1个月前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
1个月前
已完结
Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer
1个月前
已完结
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance
1个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
2个月前
已完结
An Immune Subtype Classification System Enables the Development of Strategies to Predict and Enhance Immunotherapy Responses in Colorectal Cancer
2个月前
已完结
Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody
3个月前
已完结
皖公网安备34019202002308
